Outcomes of iStent Inject Versus Kahook Dual Blade Surgery in Glaucoma Patients Undergoing Cataract Surgery. [PDF]
J Glaucoma, 2023 Précis: iStent Inject implantation (iStent) or Kahook Dual Blade goniotomy (KDB) in combination with phacoemulsification have a similar IOP-lowering effect in all stages of glaucoma, and medications are significantly reduced, especially after KDB ...
Barkander A +2 more
europepmc +2 more sources
Ab Interno Trabecular Bypass Surgery With iStent ® and iStent Inject ® for Open Angle Glaucoma
Therapeutic Delivery, 2020 Glaucoma is one of the leading causes of visual loss in industrialized world. Local lowering intra-ocular pressure drops are the first-line treatment for glaucoma. Penetrating and nonpenetrating surgery is considered when topical lowering intra-ocular pressure drops fail.
Yan Ning Neo +3 more
openaire +4 more sources
Ocular Surface Changes and Glaucoma: A Prospective Contralateral Study of IOP-Reducing Eyedrops Versus iStent Inject Surgery [PDF]
Clinical OphthalmologyKjell Gunnar Gundersen +2 more
exaly +2 more sources
iStent inject® and cataract surgery for mild-to-moderate primary open angle glaucoma in Japan: a cost-utility analysis [PDF]
International Journal of Ophthalmology, 2022 AIM: To evaluate the cost-utility of iStent inject® with cataract surgery vs cataract surgery alone in patients with mild-to-moderate primary open angle glaucoma (POAG) in the Japanese setting from a public payer's perspective.
Ataru Igarashi +7 more
doaj +1 more source
Fellow-Eye Comparison Between Phaco-Tanito Microhook Trabeculotomy and Phaco-iStent Inject W [PDF]
Journal of Clinical Medicine, 2023 Masaki Tanito, Akiko Harano, Sho Ichioka
exaly +1 more source
Ophthalmology and Therapy, 2023 Introduction This study compared outcomes of the iStent inject trabecular micro-bypass system versus the Hydrus Microstent in patients with primary open-angle glaucoma (POAG). Methods Forty subjects (80 eyes) with POAG were included in this single-center,
Mitchell Shultz +2 more
doaj +1 more source
Short-term Outcomes and Prognostic Factors of Cataract-combined Surgery with iStent versus iStent Inject [PDF]
Journal of the Korean Ophthalmological Society, 2021 Purpose: To analyze the therapeutic effects, prognostic factors, and complications that occurred after iStent<sup>®</sup> or iStent inject<sup>®</sup> implantation in South Korean glaucoma patients. Methods: We retrospectively analyzed 42 eyes of South Korean glaucoma patients, who were followed-up for more than 6 months after ...
Yeseul Gong +3 more
openaire +1 more source
Long-Term Endothelial Safety Profile With iStent Inject in Patients With Open-Angle Glaucoma [PDF]
, 2023 PURPOSE: To report 5-year postoperative safety data of iStent inject, including overall stability, endothelial cell density (ECD), and endothelial cell loss (ECL) in patients with mild-to-moderate primary open-angle glaucoma (POAG). DESIGN: 5-year follow-
L. Jay Katz +15 more
core +1 more source
Clinical &Experimental Ophthalmology, Volume 51, Issue 5, Page 437-445, July 2023., 2023 Abstract Background To investigate in combined iStent inject implantation with phacoemulsification carried out bilaterally, whether intraocular pressure (IOP)‐lowering effectiveness in the first eye has a predictive potential for the outcome of the second eye in primary open‐angle glaucoma (POAG).
David Kiessling +6 more
wiley +1 more source
Acta Ophthalmologica, Volume 100, Issue 2, Page e327-e338, March 2022., 2022 Abstract The aim of this article is to discuss how physiology and anatomical background affect the effectiveness of implant‐dependent microinvasive glaucoma surgery (MIGS). First, we provide a micro view of aqueous outflow and tissue behaviour. Second, we review studies exploring the mechanisms of the pressure‐lowering effect of MIGS, as well as tissue
Joanna Jabłońska +4 more
wiley +1 more source